0001571934-13-000002.txt : 20130905 0001571934-13-000002.hdr.sgml : 20130905 20130905135721 ACCESSION NUMBER: 0001571934-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130905 DATE AS OF CHANGE: 20130905 EFFECTIVENESS DATE: 20130905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROTROPE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001571934 IRS NUMBER: 461585656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-202382 FILM NUMBER: 131079978 BUSINESS ADDRESS: STREET 1: 10732 HAWK'S VISTA ST. CITY: PLANTATION STATE: FL ZIP: 33324 BUSINESS PHONE: 945-632-6630 MAIL ADDRESS: STREET 1: 10732 HAWK'S VISTA ST. CITY: PLANTATION STATE: FL ZIP: 33324 D 1 primary_doc.xml X0706 D LIVE 0001571934 NEUROTROPE BIOSCIENCE, INC. 10732 HAWK'S VISTA ST. PLANTATION FL FLORIDA 33324 945-632-6630 DELAWARE None None Corporation true 2012 James New 10732 Hawk's Vista Street Plantation FL FLORIDA 33324 Executive Officer Director John Abeles 10732 Hawk's Vista St Plantation FL FLORIDA 33324 Director William Singer 300 N. LaSalle c/o Kirkland & Ellis LLP Chicago IL ILLINOIS 60654 Director Ralph Bean 794 W. Shannon Road Bridgeport WV WEST VIRGINIA 26630 Director Eric Rubenstein 122 E. 42nd St c/o Intuitive Venture Partners, LLC New York NY NEW YORK 10168 Director Director at the time of the offering; no longer a director of the issuer Robert Weinstein 60 Hampden Lane Irvington NY NEW YORK 10533 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2013-08-23 false true true Upon the closing of the offering, the issuer entered into a merger in which it was the surviving corporation and became a wholly owned subsidiary of Neurotrope, Inc. 0 EDI Financial, Inc. 15699 None None 12221 Merit Drive Suite 1020 Dallas TX TEXAS 75251-2207 All States true 12613375 11533375 1080000 false 130 1128337 true 0 In addition to cash compensation of $1,128,337.50, the broker-dealer also received warrants to purchase shares of issuer stock. 0 false NEUROTROPE BIOSCIENCE, INC. James New James New President and Chief Executive Officer 2013-09-05